Invention Application
- Patent Title: A DUAL-TARGETED THERAPEUTIC PEPTIDE FOR NASOPHARYNGEAL CARCINOMA, NANOPARTICLES CARRYING SAME AND USES THEREOF
- Patent Title (中): 用于鼻咽癌的双重治疗药物，其携带的纳米颗粒及其用途
-
Application No.: US14406399Application Date: 2013-06-07
-
Publication No.: US20150344525A1Publication Date: 2015-12-03
- Inventor: Qingming Luo , Zhihong Zhang , Haiming Luo
- Applicant: HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
- Applicant Address: CN Wuhan, Hubei
- Assignee: HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
- Current Assignee: HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: CN Wuhan, Hubei
- Priority: CN201210185089.4 20120607
- International Application: PCT/CN2013/000680 WO 20130607
- Main IPC: C07K7/08
- IPC: C07K7/08 ; A61K9/51 ; A61K31/337 ; A61K31/12 ; A61K38/16 ; A61K49/00
Abstract:
Disclosed is a dual-targeted therapeutic peptide for nasopharyngeal carcinoma formed by covalently linking a targeted therapeutic peptide for nasopharyngeal carcinoma, a peptide linker and a targeted therapeutic peptide with an α-helical structure for nasopharyngeal carcinoma. Also disclosed is a nanoparticle containing the peptide. The peptide and the nanoparticle can be used to treat nasopharyngeal carcinoma.
Public/Granted literature
Information query
